ARCHIVES

FCRF Recompetition Intriguing, Involved Various Possibility

This article is from The Cancer Letter archive.

Vol. 12 No. 19 | May 9, 1986

Download PDF Visit The Full Archive

Related Articles

Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate

March 25, 2011

Breast Cancer Reports “Informative,” More Research Is Needed: Gullino

December 3, 1976

Advisers Discuss What To Do About Physician-Scientists

May 1, 1992

Senate Voices Discontent With NIH, NCI Budget; Gorton Presses Raub On Cancer’s ‘Low Priority’

March 22, 1991

NCI Advisory Group, Other Cancer Meetings

March 31, 1989

In Brief: Hammond Honored By ACS; SEER Celebrates 20th Anniversary With Symposium Dec. 8

December 3, 1993